GLP-1 Agonist plus IL-17 Inhibition in Obese Psoriatic Arthritis Save Lilly announced the topline results from its phase 3b "TOGETHER PsA" trial, showing that the combination use of ixekizumab (Taltz) and tirzepatide (Zepbound) was superior to IXE alone, yielding both significant weight loss and ACR50 disease control in adults with active psoriatic arthritis (PsA)
In iron deficiency, nuclear receptor coactivator 4 (NCOA4) specifically binds iron-rich ferritin to autophagosomes through FTH1 and transports it to the lysosome for iron release, while NCOA4 can be degraded through ubiquitination, which affects that stability of ferritin
Experimental design Sulforaphane stock solution was prepared using dimethyl sulfoxide (DMSO) and stored at 20 C
If youve increased your physical activityOpens in a new tab, you will lose more sodium, chloride, and potassium through sweat
Preoperative GLP-1 receptor agonist use and risk of postoperative respiratory complications
But it offers significant advantages: lower cost, access to dose customization, and the ability to use compounded medications that are not available in pre-filled pen format